-
Tools to Support the Fight in the Ongoing Opioid Epidemic
Aegis Director, Clinical Affairs, Joshua Schrecker, Pharm.D., has released an op-ed where he shares his firsthand experience of how fentanyl has found…
Aegis Director, Clinical Affairs, Joshua Schrecker, Pharm.D., has released an op-ed where he shares his firsthand experience of how fentanyl has found its way into known street drugs and expresses the importance of using testing as a tool to provide lifesaving treatment.
-
Citing Data Shared by Aegis Sciences, CDC Releases Publication Finding Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
As the COVID-19 Pandemic continues, there is ongoing significant interest regarding vaccine boosters and the duration of immunity after being vaccinated. …
As the COVID-19 Pandemic continues, there is ongoing significant interest regarding vaccine boosters and the duration of immunity after being vaccinated. Last week, the CDC published findings from a recent study assessing COVID-19 infections and test results during periods where Delta or Omicron cases predominated. This large study, which included over 70,000 test results and information regarding…
-
Walgreens Launches COVID-19 Index to Advance Rapid Detection of Omicron and Track Variant Activity by State
Data captured in the Walgreens COVID-19 Index tracks existing and emerging variants DEERFIELD, Ill., and NASHVILLE, Tenn., January 19, 2022 –The Walgreens…
Data captured in the Walgreens COVID-19 Index tracks existing and emerging variants DEERFIELD, Ill., and NASHVILLE, Tenn., January 19, 2022 –The Walgreens COVID-19 Index, a new interactive tracking tool from Walgreens, powered by testing data from Aegis Sciences Corporation, is among the first to uniquely identify the spread of current and emerging variants in near real-time.New data from the Walgreens…
-
Aegis Sciences Corporation Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
HITRUST CSF Certification validates Aegis Sciences Corporation is committed to meeting key regulations and protecting sensitive information. Nashville,…
HITRUST CSF Certification validates Aegis Sciences Corporation is committed to meeting key regulations and protecting sensitive information. Nashville, TN, January 10, 2022 – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, today announced that several of its applications* have earned Certified…
-
National Surveillance of COVID-19
In response to the ongoing COVID-19 pandemic, Aegis Sciences Corporation and Walgreens have collaborated to make real-time reverse transcriptase polymerase…
In response to the ongoing COVID-19 pandemic, Aegis Sciences Corporation and Walgreens have collaborated to make real-time reverse transcriptase polymerase chain reaction (RT-PCR) testing readily available at more than 5,200 of the over 7,200 Walgreens locations that provide COVID-19 testing. As the virus that causes COVID-19 continues to mutate, both organizations have worked diligently to closely…
-
Aegis Sciences Corporation Expands Oral Fluid Testing to include Novel Psychoactive Substances
Nashville, Tennessee (December 6, 2021) - Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…
Nashville, Tennessee (December 6, 2021) - Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, is pleased to announce the expansion of oral fluid testing to include novel psychoactive substance (NPS). Testing includes expanded offerings for designer opioids, designer benzodiazepines, synthetic…
-
Aegis Sciences Launches Infectious Disease Testing
New product offers highly sensitive and specific, molecular testing solutions for common infectious diseases. Nashville, Tennessee (October 11, 2021) –…
New product offers highly sensitive and specific, molecular testing solutions for common infectious diseases. Nashville, Tennessee (October 11, 2021) – Aegis Sciences Corporation has expanded its molecular testing capabilities to rapidly identify pathogens in the respiratory and urogenital health spaces. With Aegis Infectious Disease Testing, providers will have access to: Clinically relevant tests…
-
National Surveillance of COVID-19 Infections: Variants, Vaccination Status, and Viral Spread
Aegis Sciences Corporation and Walgreens are collaborating to significantly improve access COVID-19 diagnostic testing throughout the United States. In…
Aegis Sciences Corporation and Walgreens are collaborating to significantly improve access COVID-19 diagnostic testing throughout the United States. In May 2021, Aegis began performing whole genome sequencing on samples identified as positive to assist in surveillance of transmissible viral variants. This has allowed for reporting of viral lineages from over 110,000 samples, accounting for ~15% of…
-
Aegis Launches COVID-19 Testing Program for Schools
TestingWorks! helps schools stay open through simple, cost-effective, pooled testing Nashville, Tennessee (June 10, 2021) – Today, Aegis Sciences Corporation…
TestingWorks! helps schools stay open through simple, cost-effective, pooled testing Nashville, Tennessee (June 10, 2021) – Today, Aegis Sciences Corporation launched TestingWorks! to help keep schools open during the COVID-19 pandemic through pooled testing. This testing program was designed to be simple for schools to use while reducing costs and increasing access to testing. “We’re at a critical…
-
Aegis Sciences Announces Additional Longer Term CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19
Nashville, Tennessee (April 26, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication…
Nashville, Tennessee (April 26, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services, is pleased to announce that it has entered into a long term agreement with the Centers for Disease Control and Prevention (CDC) to deliver 10,000 SARS-CoV-2 genomic sequences per week to enable strain identification…
